. Citrated blood was incubated with NaCl or various concentrations of NU172 aptamer, AD, or NS_AD for 2 min. Afterwards, the coagulation was activated by pathromtin and CaCl2 (n = 10) and measured with PIEZ and KC 1A. Using PIEZ, the clotting time (CT), viscous (η') and elastic (η") components at 300 s, and linear slopes (m(η') and m(η")) were measured 1 . Sample PIEZ KC 1A PIEZ CT/s CT/s η'(Pas) at 300 s η"(Pas) at 300 s m(η'/Pa) m(η"/Pa)
µM NU172
62.2 ± 1.9 63.3 ± 4.0 3.7 × 10 −3 ± 3.7 × 10 −4 3.4 × 10 −3 ± 6.1 × 10 −4 7.8 × 10 −5 ± 1.6 × 10 −5 6.8 × 10 −5 ± 2.2 × 10 −5 1.0 µM NU172 78.7 ± 3.1 79.4 ± 8.0 3.5 × 10 −3 ± 2.6 × 10 −4 3.2 × 10 −3 ± 3.8 × 10 −4 4.9 × 10 −5 ± 1.3 × 10 −5 4.2 × 10 −5 ± 2.2 × 10 −5
215.0 ± 10.7 211.6 ± 10.4 2.5 × 10 −3 ± 3.6 × 10 −4 1.6 × 10 −3 ± 2.6 × 10 −4 1.1 × 10 −5 ± 3.5 × 10 −6 1.4 × 10 −5 ± 2.5 × 10 −6 2.0 µM NU172 249.1 ± 10.5 248.9 ± 14.6 2.1 × 10 −3 ± 2.8 × 10 −4 1.4 × 10 −3 ± 2.4 × 10 −4 8.3 × 10 −6 ± 3.1 × 10 −6 1.2 × 10 −5 ± 2.5 × 10 −6 1.0 µM AD 52.7 ± 1.1 52.4 ± 1.9 2.9 × 10 −3 ± 2.0 × 10 −4 3.5 × 10 −3 ± 4.6 × 10 −4 5.9 × 10 −5 ± 6.7 × 10 −6 9.1 × 10 −5 ± 1.2 × 10 −5 Table S2 . Citrated blood was incubated with NaCl or various concentrations of NU172 aptamer for 2 min. Then, 1.0 µM AD was added and after 5 min the blood samples were activated with pathromtin and CaCl2. (n = 5). The measurement was performed with PIEZ and KC 1A. Using PIEZ, the clotting time (CT), viscous (η') and elastic (η") components at 300 s, and linear slopes (m(η') and m(η")) were measured 1 . Table S3 . Heparinized blood was incubated with NaCl, NU172 aptamer, NS_AD, or AD. After 2 min of incubation, the coagulation was activated with plasma cephalin and factor Xa. (n = 10). The measurement was performed with PIEZ and KC 1A. Using PIEZ, the clotting time (CT), viscous (η') and elastic (η") components at 300 s, and linear slopes (m(η') and m(η")) were measured 1 . Table S4 . Heparinized blood was incubated for 2 min with 1.0 µM NU172, then 1.0 µM AD was added to the NU172 aptamer containing blood and incubated for 5 min. The clotting time (CT) was determined before and after the circulation for 30 min at 37 °C in an in vitro rotation model using PIEZ or KC 1A. Blood without any additives was indicated as a baseline. Blood with NaCl, 1.0 µM NS_AD, or AD were used as negative controls. Blood with 1.0 µM NU172 served as positive control. Blood from five different volunteers was used (n = 5 ± SD). Using PIEZ, the clotting time (CT), viscous (η') and elastic (η") components at 300 s, and linear slopes (m(η') and m(η")) were measured 1 . 
Sample

